Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- OncoTree
- BREAST
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04997798 | Dalpiciclib in Combination With Exemestane and Trastuzumab Plus Pyrotinib in Early Triple Positive Breast Cancer | unknown | Phase 2 | 30 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT05430347 | Clinical Study of Pyrotinib in Neoadjuvant Therapy of HR-positive and HER2-positive Breast Cancer | unknown | Phase 2 | 80 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Feb 21, 2023 |
| clinicaltrials |
| NCT05733026 | Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients | unknown | — | 200 | Ain Shams UniversityOTHER | 1 | Feb 17, 2023 | clinicaltrials |
| NCT05386524 | Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBC | unknown | Phase 2 | 41 | Fudan UniversityOTHER | 1 | Feb 16, 2023 | clinicaltrials |
| NCT02983071 | G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 102 | G1 Therapeutics, Inc.INDUSTRY | 4 | Feb 15, 2023 | clinicaltrials |
| NCT04857229 | Histolog Comparison to Standard Histology(HiCoSH) | unknown | — | 101 | Imperial College LondonOTHER | 1 | Feb 14, 2023 | clinicaltrials |
| NCT05726643 | Effect of Kinesiotaping Augmented By Resistive Exercise on Fatigue, Physical Strength, Quality of Life in Breast Cancer Survivors | unknown | N/A | 40 | Cairo UniversityOTHER | 1 | Feb 14, 2023 | clinicaltrials |
| NCT05724407 | Molecular Signature for Breast Cancer(MoSi4BCa) | unknown | — | 220 | Assistance Publique - Hôpitaux de ParisOTHER | 0 | Feb 13, 2023 | clinicaltrials |
| NCT05724758 | Patient Reported Outcomes After Oncoplastic Breast Conserving Surgery | unknown | — | 100 | Brust-Zentrum AGOTHER | 0 | Feb 13, 2023 | clinicaltrials |
| NCT05726175 | Disitamab Vedotin(RC48) Combined With Penpulimab(AK105) for Neoadjuvant Treatment of HER2-low Breast Cancer | unknown | Phase 2 | 20 | West China HospitalOTHER | 1 | Feb 13, 2023 | clinicaltrials |
| NCT05720026 | Study to Evaluate the Efficacy and Safety of SYSA1901 vs. Perjeta® of HER2-Positive Breast Cancer | unknown | Phase 3 | 560 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Feb 9, 2023 | clinicaltrials |
| NCT05720858 | Telerehabilitation in Survival Breast Cancer Patients | unknown | N/A | 69 | Hasan Kalyoncu UniversityOTHER | 1 | Feb 9, 2023 | clinicaltrials |
| NCT04438564 | Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients | unknown | N/A | 300 | China Medical University HospitalOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05717634 | Endometrial Changes in Breast Cancer Women. | unknown | — | 829 | Regina Elena Cancer InstituteOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05070884 | Clinical Validation of Radiomics Artificial Intelligence: Application to Breast Cancer Treatment Planning(RADIOVAL) | unknown | — | 5,000 | Instituto de Investigacion Sanitaria La FeOTHER | 8 | Feb 3, 2023 | clinicaltrials |
| NCT05369546 | Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis | unknown | — | 600 | University of HawaiiOTHER | 1 | Feb 2, 2023 | clinicaltrials |
| NCT04815616 | Efficacy of Capecitabine With Adjuvant Radiotherapy in Treatment of Early Stages Breast Cancer (Retrospective Study). | unknown | — | 47 | Assiut UniversityOTHER | 0 | Feb 1, 2023 | clinicaltrials |
| NCT05453825 | A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors | unknown | Phase 2 | 180 | OncXerna Theraputics, Inc.INDUSTRY | 1 | Jan 31, 2023 | clinicaltrials |
| NCT05609058 | The Influence of Treatment Position (Prone vs. Supine) on Whole Breast Target | unknown | N/A | 300 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jan 31, 2023 | clinicaltrials |
| NCT05703815 | EpCAM and p53 Expressions in Infiltrating Duct Carcinoma of the Breast | unknown | — | 40 | Sohag UniversityOTHER | 0 | Jan 31, 2023 | clinicaltrials |
| NCT05266378 | Pectoralis Nerve Block and Quality of Recovery in Mastectomy Patients | unknown | N/A | 156 | Gangnam Severance HospitalOTHER | 1 | Jan 20, 2023 | clinicaltrials |
| NCT05692661 | A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer | unknown | Phase 1 | 24 | Shanghai Proton and Heavy Ion CenterOTHER | 1 | Jan 20, 2023 | clinicaltrials |
| NCT05017337 | Breast-implant ASsocIated anaplastIc Large Cell Lymphoma and CApsular Contracture(BASILICA) | unknown | — | 100 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 19, 2023 | clinicaltrials |
| NCT04248998 | Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer(BREAKFAST) | unknown | Phase 2 | 30 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Jan 18, 2023 | clinicaltrials |
| NCT04574063 | PIONEER Study of Lifestyle Intervention to Reduced Breast Cancer Risk(PIONEER) | unknown | N/A | 240 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 18, 2023 | clinicaltrials |
| NCT04579029 | PRELUDE Study of Lymphatic Surgery to Treat Breast Cancer Related Lymphoedema(PRELUDE) | unknown | N/A | 64 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 18, 2023 | clinicaltrials |
| NCT04582968 | Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases | unknown | Phase 1 / Phase 2 | 39 | Fudan UniversityOTHER | 1 | Jan 18, 2023 | clinicaltrials |
| NCT02914158 | Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women(ASPAIT) | unknown | Phase 3 | 680 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Jan 17, 2023 | clinicaltrials |
| NCT05686720 | Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Advanced Triple Negative Breast Cancer | unknown | Early Phase 1 | 12 | First Affiliated Hospital of Shantou University Medical CollegeOTHER | 1 | Jan 17, 2023 | clinicaltrials |
| NCT04808674 | Remediation for Mild Cognitive Deficits After Cancer(EURECA) | unknown | N/A | 24 | Hospices Civils de LyonOTHER | 1 | Jan 13, 2023 | clinicaltrials |
| NCT05684458 | The Effect of Reiki on Symptom Control and Quality of Life in Breast Cancer Patients | unknown | N/A | 52 | Ankara Medipol UniversityOTHER | 0 | Jan 13, 2023 | clinicaltrials |
| NCT05681728 | A Phase II Study Evaluating the Efficacy and Safety of Pembrolizumab in Combination With Chemotherapy as Neoadjuvant Therapy for Triple-negative Breast Cancer | unknown | Phase 2 | 26 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jan 12, 2023 | clinicaltrials |
| NCT05680662 | The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism | unknown | Early Phase 1 | 200 | Ministry of Health, Saudi ArabiaOTHER_GOV | 0 | Jan 11, 2023 | clinicaltrials |
| NCT05544123 | The Treatment Situation of Chinese County Population With Breast Cancer | unknown | — | 2,500 | The First Affiliated Hospital of Xinxiang Medical CollegeOTHER | 1 | Jan 4, 2023 | clinicaltrials |
| NCT05670054 | Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients | unknown | Phase 3 | 116 | Mansoura UniversityOTHER | 1 | Jan 4, 2023 | clinicaltrials |
| NCT03775525 | Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer(GEN602) | unknown | Phase 1 | 127 | Genzada Pharmaceuticals USA, Inc.INDUSTRY | 1 | Dec 23, 2022 | clinicaltrials |
| NCT05661656 | Catheter Guided Chemo-infusion in Breast Cancer | unknown | N/A | 50 | Assiut UniversityOTHER | 0 | Dec 22, 2022 | clinicaltrials |
| NCT05656079 | To Evaluate the Cardiac Safety of Pegylated Liposomal Doxorubicin Concurrently Plus Trastuzumab and Pertuzumab in the Adjuvant Setting for Early-stage HER-2-positive Breast Cancer: a Multicenter, Randomized Controlled Clinical Study(easy laugh) | unknown | N/A | 204 | Shanghai Pudong HospitalOTHER | 1 | Dec 19, 2022 | clinicaltrials |
| NCT05654571 | Weight Loss and Breast Cancer | unknown | — | 300 | Fatih Sultan Mehmet Training and Research HospitalOTHER | 1 | Dec 16, 2022 | clinicaltrials |
| NCT03162289 | Intermittent Fasting Accompanying Chemotherapy in Gynecological Cancers(FIT2) | unknown | N/A | 150 | Charite University, Berlin, GermanyOTHER | 1 | Dec 13, 2022 | clinicaltrials |
| NCT04001621 | Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Dec 8, 2022 | clinicaltrials |
| NCT04433494 | A Study of TY-302 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 60 | TYK Medicines, IncINDUSTRY | 1 | Dec 7, 2022 | clinicaltrials |
| NCT05588973 | Prevention of Radiodermatitis in Breast and Head and Neck Cancer Patients in Cyprus(MEDISKIN) | unknown | N/A | 100 | Angelos KassianosOTHER | 1 | Dec 6, 2022 | clinicaltrials |
| NCT05637528 | Evaluating the Use of Magnetic Resonance Imaging and Contrast Enhanced Mammography After MagTrace® Use(MagTrace2) | unknown | — | 25 | Zuyderland Medisch CentrumOTHER | 0 | Dec 5, 2022 | clinicaltrials |
| NCT05619016 | [68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors | unknown | Phase 2 | 72 | Karolinska University HospitalOTHER | 1 | Nov 30, 2022 | clinicaltrials |
| NCT05454553 | Efficacity of Deep Inspiration Breath Hold and Intensity-modulated Radiotherapy in Preventing PErfusion Defect for Left Sided Breast Cancer (EDIPE)(EDIPE) | unknown | N/A | 58 | Institut de cancérologie Strasbourg EuropeOTHER | 1 | Nov 29, 2022 | clinicaltrials |
| NCT05623280 | Artificial Intelligence Analysis of Fluorescence Image to Intraoperatively Detect Metastatic Sentinel Lymph Node. | unknown | — | 40 | Xiang'an Hospital of Xiamen UniversityOTHER | 1 | Nov 28, 2022 | clinicaltrials |
| NCT03863223 | A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer | unknown | Phase 3 | 590 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Nov 23, 2022 | clinicaltrials |
Data updated 24 days agoSource updated Feb 21, 2023source: clinicaltrials